|
EP0590058B1
(en)
|
1991-06-14 |
2003-11-26 |
Genentech, Inc. |
HUMANIZED Heregulin ANTIBODy
|
|
US6214345B1
(en)
|
1993-05-14 |
2001-04-10 |
Bristol-Myers Squibb Co. |
Lysosomal enzyme-cleavable antitumor drug conjugates
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
US6949245B1
(en)
|
1999-06-25 |
2005-09-27 |
Genentech, Inc. |
Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 antibodies
|
|
US6926898B2
(en)
|
2000-04-12 |
2005-08-09 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
|
FR2807767B1
(fr)
|
2000-04-12 |
2005-01-14 |
Lab Francais Du Fractionnement |
Anticorps monoclonaux anti-d
|
|
US7256257B2
(en)
|
2001-04-30 |
2007-08-14 |
Seattle Genetics, Inc. |
Pentapeptide compounds and uses related thereto
|
|
US6884869B2
(en)
|
2001-04-30 |
2005-04-26 |
Seattle Genetics, Inc. |
Pentapeptide compounds and uses related thereto
|
|
US7091186B2
(en)
|
2001-09-24 |
2006-08-15 |
Seattle Genetics, Inc. |
p-Amidobenzylethers in drug delivery agents
|
|
ES2369542T3
(es)
|
2002-07-31 |
2011-12-01 |
Seattle Genetics, Inc. |
Conjugados de auristatina y su uso para tratar cáncer, una enfermedad autoinmune o una enfermedad infecciosa.
|
|
US8399618B2
(en)
|
2004-10-21 |
2013-03-19 |
Xencor, Inc. |
Immunoglobulin insertions, deletions, and substitutions
|
|
ES2605443T3
(es)
|
2003-11-06 |
2017-03-14 |
Seattle Genetics, Inc. |
Conjugados de auristatina con anticuerpos anti-HER2 o anti-CD22 y su uso en terapia
|
|
CA2556752C
(en)
|
2004-02-23 |
2016-02-02 |
Genentech, Inc. |
Heterocyclic self-immolative linkers and conjugates
|
|
TR201808537T4
(tr)
|
2004-09-23 |
2018-07-23 |
Genentech Inc |
Sistein değiştirilmiş antikorlar ve konjugatlar.
|
|
AU2006230413B8
(en)
|
2005-03-31 |
2011-01-20 |
Xencor, Inc |
Fc variants with optimized properties
|
|
GB0619291D0
(en)
|
2006-09-29 |
2006-11-08 |
Ucb Sa |
Altered antibodies
|
|
JP2010510500A
(ja)
*
|
2006-11-24 |
2010-04-02 |
ジェミナ アセット マネージメント (6) ピーティーワイ リミテッド |
電源監視システム
|
|
PL2099823T5
(pl)
|
2006-12-01 |
2023-02-20 |
Seagen Inc. |
Wariant środków wiążących cel i jego zastosowania
|
|
CN102711810B
(zh)
|
2009-11-30 |
2015-04-22 |
詹森生物科技公司 |
效应子功能已消除的抗体Fc区突变体
|
|
CA2784610C
(en)
|
2009-12-23 |
2020-07-14 |
Avipep Pty Ltd |
Immuno-conjugates and methods for producing them
|
|
TW201141519A
(en)
*
|
2010-03-04 |
2011-12-01 |
Symphogen As |
Anti-HER2 antibodies and compositions
|
|
WO2011135040A1
(en)
|
2010-04-30 |
2011-11-03 |
F. Hoffmann-La Roche Ag |
Fluorescent antibody fusion protein, its production and use
|
|
CA3220104A1
(en)
|
2010-06-08 |
2011-12-15 |
Genentech, Inc. |
Cysteine engineered antibodies and conjugates
|
|
CN103429620B
(zh)
|
2010-11-05 |
2018-03-06 |
酵活有限公司 |
在Fc结构域中具有突变的稳定异源二聚的抗体设计
|
|
AU2012222833B2
(en)
|
2011-03-03 |
2017-03-16 |
Zymeworks Inc. |
Multivalent heteromultimer scaffold design and constructs
|
|
LT2691417T
(lt)
|
2011-03-29 |
2018-10-25 |
Roche Glycart Ag |
Antikūno fc variantai
|
|
US20140170148A1
(en)
|
2011-04-20 |
2014-06-19 |
Genmab A/S |
Bispecific antibodies against her2
|
|
BR112013027173B1
(pt)
*
|
2011-04-29 |
2019-08-06 |
Becton, Dickinson And Company |
Sistema de classificador de célula, método para calibrar um sistema de classificador de célula, e sistema de controle de retardo de carga para um citômetro de fluxo
|
|
US9574010B2
(en)
|
2011-11-04 |
2017-02-21 |
Zymeworks Inc. |
Stable heterodimeric antibody design with mutations in the Fc domain
|
|
BR112014031613A2
(pt)
*
|
2012-06-19 |
2017-07-25 |
Polytherics Ltd |
processo para preparação de conjugados de anticorpos e conjugados de anticorpos
|
|
IN2015DN01115A
(cg-RX-API-DMAC7.html)
|
2012-07-13 |
2015-06-26 |
Zymeworks Inc |
|
|
EP2906591A1
(en)
|
2012-10-15 |
2015-08-19 |
Universität Zürich |
Bispecific her2 ligands for cancer therapy
|
|
PT3199552T
(pt)
|
2012-11-20 |
2020-03-25 |
Sanofi Sa |
Anticorpos anti-ceacam5 e suas utilizações
|
|
EP2777714A1
(en)
|
2013-03-15 |
2014-09-17 |
NBE-Therapeutics LLC |
Method of producing an immunoligand/payload conjugate by means of a sequence-specific transpeptidase enzyme
|
|
TW201519904A
(zh)
|
2013-03-15 |
2015-06-01 |
Abbvie Inc |
抗體藥物結合物(adc)之純化
|
|
US10239951B2
(en)
*
|
2013-05-08 |
2019-03-26 |
Zymeworks Inc. |
Bispecific HER2 and HER3 antigen binding constructs
|
|
EP3004174B1
(en)
|
2013-05-31 |
2019-04-17 |
Zymeworks Inc. |
Heteromultimers with reduced or silenced effector function
|
|
US9877080B2
(en)
*
|
2013-09-27 |
2018-01-23 |
Samsung Electronics Co., Ltd. |
Display apparatus and method for controlling thereof
|
|
PT3480215T
(pt)
|
2013-11-19 |
2021-07-05 |
Remegen Ltd |
Anticorpo anti-her2 e seu conjugado
|
|
LT3074424T
(lt)
*
|
2013-11-27 |
2025-05-26 |
Zymeworks Bc Inc. |
Bispecifiniai antigeną surišantys konstruktai, nukreipti į her2
|
|
JP6510532B2
(ja)
|
2013-12-20 |
2019-05-08 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
二重特異性her2抗体及び使用方法
|
|
KR102384740B1
(ko)
*
|
2013-12-27 |
2022-04-07 |
자임워크스 인코포레이티드 |
약물 접합체를 위한 설폰아마이드-함유 연결 시스템
|
|
WO2015104373A2
(en)
|
2014-01-10 |
2015-07-16 |
Synthon Biopharmaceuticals B.V. |
Duocarmycin adcs for use in treatment of endometrial cancer
|
|
TWI754319B
(zh)
*
|
2014-03-19 |
2022-02-01 |
美商再生元醫藥公司 |
用於腫瘤治療之方法及抗體組成物
|
|
CA2943299A1
(en)
|
2014-04-11 |
2015-10-15 |
Medimmune, Llc |
Bispecific her2 antibodies
|
|
DK3151865T3
(da)
|
2014-05-22 |
2021-10-25 |
Byondis Bv |
Stedsspecifik konjugation af linker medicin til antistof og resulterende adcs
|
|
US9132096B1
(en)
|
2014-09-12 |
2015-09-15 |
Alkermes Pharma Ireland Limited |
Abuse resistant pharmaceutical compositions
|
|
ES2905569T3
(es)
*
|
2014-09-17 |
2022-04-11 |
Zymeworks Inc |
Compuestos citotóxicos y antimitóticos y métodos para utilizarlos
|
|
FI3223848T3
(fi)
*
|
2014-11-27 |
2025-02-28 |
Zymeworks Bc Inc |
Menetelmiä käyttää bispesifisiä antigeenia sitovia rakenteita, jotka kohdistuvat her2:een
|
|
CA2984458A1
(en)
*
|
2015-05-13 |
2016-11-17 |
Zymeworks Inc. |
Antigen-binding constructs targeting her2
|
|
EP3383909B1
(en)
|
2015-11-30 |
2020-06-17 |
AbbVie Inc. |
Anti-human lrrc15 antibody drug conjugates and methods for their use
|
|
WO2017185177A1
(en)
|
2016-04-25 |
2017-11-02 |
Zymeworks Inc. |
Methods of using bispecific antigen-binding constructs targeting her2
|
|
RS61659B1
(sr)
|
2016-05-17 |
2021-04-29 |
Abbvie Biotherapeutics Inc |
Konjugati antitelo lek anti-cmet i metode za njihovu upotrebu
|
|
CN107446045A
(zh)
*
|
2016-07-22 |
2017-12-08 |
北京天广实生物技术股份有限公司 |
一种抗her2的抗体、其药物组合物及用途
|
|
US10377833B2
(en)
|
2016-07-22 |
2019-08-13 |
Beijing Mabworks Biotech Co., Ltd. |
Bispecific anti-HER2 antibody
|
|
AU2019235634A1
(en)
|
2018-03-13 |
2020-10-22 |
Zymeworks Bc Inc. |
Anti-HER2 biparatopic antibody-drug conjugates and methods of use
|